These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 34831090)

  • 1. TMEM16A/ANO1: Current Strategies and Novel Drug Approaches for Cystic Fibrosis.
    Mitri C; Sharma H; Corvol H; Tabary O
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of Anoctamin 1/TMEM16A calcium-activated chloride channels in airways of in vivo mouse models for cystic fibrosis research.
    Hahn A; Salomon JJ; Leitz D; Feigenbutz D; Korsch L; Lisewski I; Schrimpf K; Millar-Büchner P; Mall MA; Frings S; Möhrlen F
    Pflugers Arch; 2018 Sep; 470(9):1335-1348. PubMed ID: 29860639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma membrane-localized TMEM16 proteins are indispensable for expression of CFTR.
    Benedetto R; Ousingsawat J; Cabrita I; Pinto M; Lérias JR; Wanitchakool P; Schreiber R; Kunzelmann K
    J Mol Med (Berl); 2019 May; 97(5):711-722. PubMed ID: 30915480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial Chloride Transport by CFTR Requires TMEM16A.
    Benedetto R; Ousingsawat J; Wanitchakool P; Zhang Y; Holtzman MJ; Amaral M; Rock JR; Schreiber R; Kunzelmann K
    Sci Rep; 2017 Sep; 7(1):12397. PubMed ID: 28963502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis.
    Ruffin M; Voland M; Marie S; Bonora M; Blanchard E; Blouquit-Laye S; Naline E; Puyo P; Le Rouzic P; Guillot L; Corvol H; Clement A; Tabary O
    Biochim Biophys Acta; 2013 Dec; 1832(12):2340-51. PubMed ID: 24080196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMEM16A (ANO1) as a therapeutic target in cystic fibrosis.
    Galietta LJV
    Curr Opin Pharmacol; 2022 Jun; 64():102206. PubMed ID: 35364521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systems Approaches to Unravel Molecular Function: High-content siRNA Screen Identifies TMEM16A Traffic Regulators as Potential Drug Targets for Cystic Fibrosis.
    Pinto MC; Botelho HM; Silva IAL; Railean V; Neumann B; Pepperkok R; Schreiber R; Kunzelmann K; Amaral MD
    J Mol Biol; 2022 Mar; 434(5):167436. PubMed ID: 34990652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells.
    Edlund A; Esguerra JL; Wendt A; Flodström-Tullberg M; Eliasson L
    BMC Med; 2014 May; 12():87. PubMed ID: 24885604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TMEM16A: An Alternative Approach to Restoring Airway Anion Secretion in Cystic Fibrosis?
    Danahay H; Gosling M
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel microscopy-based assay identifies extended synaptotagmin-1 (ESYT1) as a positive regulator of anoctamin 1 traffic.
    Lérias JR; Pinto MC; Botelho HM; Awatade NT; Quaresma MC; Silva IAL; Wanitchakool P; Schreiber R; Pepperkok R; Kunzelmann K; Amaral MD
    Biochim Biophys Acta Mol Cell Res; 2018 Feb; 1865(2):421-431. PubMed ID: 29154949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia.
    Veit G; Bossard F; Goepp J; Verkman AS; Galietta LJ; Hanrahan JW; Lukacs GL
    Mol Biol Cell; 2012 Nov; 23(21):4188-202. PubMed ID: 22973054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tgf-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia.
    Sun H; Harris WT; Kortyka S; Kotha K; Ostmann AJ; Rezayat A; Sridharan A; Sanders Y; Naren AP; Clancy JP
    PLoS One; 2014; 9(9):e106842. PubMed ID: 25268501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.
    Danahay HL; Lilley S; Fox R; Charlton H; Sabater J; Button B; McCarthy C; Collingwood SP; Gosling M
    Am J Respir Crit Care Med; 2020 Apr; 201(8):946-954. PubMed ID: 31898911
    [No Abstract]   [Full Text] [Related]  

  • 14. New horizons in the treatment of cystic fibrosis.
    Cuthbert AW
    Br J Pharmacol; 2011 May; 163(1):173-83. PubMed ID: 21108631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compartmentalized crosstalk of CFTR and TMEM16A (ANO1) through EPAC1 and ADCY1.
    Lérias J; Pinto M; Benedetto R; Schreiber R; Amaral M; Aureli M; Kunzelmann K
    Cell Signal; 2018 Apr; 44():10-19. PubMed ID: 29331508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative chloride transport pathways as pharmacological targets for the treatment of cystic fibrosis.
    Quesada R; Dutzler R
    J Cyst Fibros; 2020 Mar; 19 Suppl 1():S37-S41. PubMed ID: 31662238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bypassing CFTR dysfunction in cystic fibrosis with alternative pathways for anion transport.
    Li H; Salomon JJ; Sheppard DN; Mall MA; Galietta LJ
    Curr Opin Pharmacol; 2017 Jun; 34():91-97. PubMed ID: 29065356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological analysis of epithelial chloride secretion mechanisms in adult murine airways.
    Gianotti A; Ferrera L; Philp AR; Caci E; Zegarra-Moran O; Galietta LJ; Flores CA
    Eur J Pharmacol; 2016 Jun; 781():100-8. PubMed ID: 27063443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting autophagy as a novel strategy for facilitating the therapeutic action of potentiators on ΔF508 cystic fibrosis transmembrane conductance regulator.
    Luciani A; Villella VR; Esposito S; Gavina M; Russo I; Silano M; Guido S; Pettoello-Mantovani M; Carnuccio R; Scholte B; De Matteis A; Maiuri MC; Raia V; Luini A; Kroemer G; Maiuri L
    Autophagy; 2012 Nov; 8(11):1657-72. PubMed ID: 22874563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The TMEM16A chloride channel as an alternative therapeutic target in cystic fibrosis.
    Sondo E; Caci E; Galietta LJ
    Int J Biochem Cell Biol; 2014 Jul; 52():73-6. PubMed ID: 24704530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.